The potential of circulating tumor DNA (ctDNA) to reshape the design of clinical trials testing adjuvant therapy in patients with early stage cancers.
暂无分享，去创建一个
R. Strausberg | K. Kinzler | B. Vogelstein | P. Gibbs | M. Christie | J. Desai | L. Diaz | N. Papadopoulos | Lu Li | Yuxuan Wang | J. Tie | C. Tomasetti | B. Tran | S. Springer | I. Kinde | A. Haydon | R. Wong | S. Kosmider | T. Hayes | D. Yip